Structures by: Geffken D.
Total: 5
<i>N</i>-(1-Allyl-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide hemihydrate
2(C17H17N3O3S),H2O
Acta Crystallographica Section E (2013) 69, 10 o1589-o1590
a=8.2099(7)Å b=13.8928(12)Å c=15.0495(14)Å
α=90.00° β=92.327(3)° γ=90.00°
2-Ethoxy-5-methylbis[1,2,4]triazolo[1,5-<i>a</i>:4',3'-<i>c</i>]quinazoline
C13H12N6O
Acta Crystallographica Section E (2012) 68, 1 o101
a=7.4121(11)Å b=19.240(3)Å c=9.3096(14)Å
α=90.00° β=109.051(2)° γ=90.00°
Ethyl 3-[7-ethoxy-6-(4-methoxybenzenesulfonamido)-2<i>H</i>-indazol-2-yl]propanoate
C21H25N3O6S
Acta Crystallographica Section E (2012) 68, 4 o931
a=9.1163(4)Å b=10.9161(5)Å c=11.2959(5)Å
α=77.259(2)° β=77.364(2)° γ=88.562(2)°
6-Amino-4-(3-iodoanilino)-2-methylpyrimidin-1-ium chloride
C11H12IN4,Cl
Acta Crystallographica Section E (2012) 68, 7 o2235
a=12.6323(5)Å b=19.8608(7)Å c=5.1267(2)Å
α=90.00° β=90.00° γ=90.00°
4-Methoxy-<i>N</i>-(1-methyl-1<i>H</i>-indazol-5-yl)benzenesulfonamide
C15H15N3O3S
Acta Crystallographica Section E (2013) 69, 9 o1398
a=10.1069(3)Å b=13.6178(3)Å c=10.8530(2)Å
α=90.00° β=90.777(2)° γ=90.00°